Giannis Mountzios (Author), J. Remon (Author), Silvia Novello (Author), N. Blais (Author), R. Califano (Author), Tanja Čufer (Author), Anne-Marie C. Dingemans (Author), S. V. Liu (Author), N. Peled (Author), N. A. Pennell (Author)

Abstract

Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of >= 1 by the USA Food and Drug Administration

Keywords

raziskava KEYNOTE-024;pemrolizumab;zdravljenje;KEYNOTE-024 trial;treatment;

Data

Language: English
Year of publishing:
Typology: 1.03 - Short Scientific Article
Publisher: Elsevier
UDC: 616.2
COBISS: 2048615281 Link will open in a new window
ISSN: 1569-8041
Views: 796
Downloads: 432
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary keywords: Carcinoma, non-small cell lung;Drug therapy;Nedrobnocelični karcinom pljuč;Terapija z zdravili;
Source comment: Nasl. z nasl. zaslona; Soavtorica iz Slovenije: T. Cufer; Opis vira z dne 15. 1. 2020;
Pages: str. 1686-1688
Volume: ǂVol. ǂ30
Issue: ǂiss. ǂ11
Chronology: Nov. 2019
DOI: 10.1093/annonc/mdz295
ID: 12036970